Search results
BioNTech and CEPI expand deal to boost Africa’s vaccine capabilities
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoBioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced an expansion...
Emergent (EBS) Initiates Study on Lassa Virus Vaccine Candidate
Zacks via Yahoo Finance· 2 years agoEmergent BioSolutions EBS announced the dosing of the first patient in a phase I study evaluating...
Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious...
Benzinga via Yahoo Finance· 2 years agoInovio Pharmaceuticals Inc (NASDAQ: INO) has agreed with its collaborator, the Coalition for...
COVID-19 vaccine scheme for poorest has $2.6bn left to spend as pandemic recedes
Reuters via Yahoo News· 12 months agoSeveral billions of dollars left in a scheme to deliver COVID-19 vaccines to the world’s poorest...
BioNTech gets $145 million funding for African vaccine plants
Reuters via AOL· 2 weeks agoFRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from...
BioNTech wins up to $90 million in funding for mpox vaccine development
Reuters via AOL· 9 months agoBioNTech would initiate an early-to-mid stage trial for the vaccine program BNT166 to prevent mpox,...
British agencies win CEPI funds to develop standard monkeypox tools
Reuters via Yahoo News· 2 years agoLONDON (Reuters) -British health agencies have secured funding to develop a standardised approach to...
New U.S. Rules for Dangerous Pathogen Research, Explained
The Dispatch via Yahoo News· 2 weeks agoA colorized transmission electron micrograph shows Ebola virus particles in gold. (Courtesy:...
Without a nasal vaccine, the U.S. edge in fighting Covid is on the line
Politico via Yahoo News· 2 years agoBiden administration officials are raising concerns that the slow pace of developing a nasal vaccine...
Novavax (NVAX) Down 7.6% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for Novavax (NVAX). Shares have lost about 7.6%...